Company: CPMV
Filing Date: 2025-08-19
Form Type: 10-Q
Source: 0001683168-25-006318
Chunk: 28

Company: Mosaic ImmunoEngineering Inc.
Filing Date: 2025-08-19
Form: 10-Q
Item: Part I, Item 1
Chunk 28
---
 S-K.

    Item 6.
    Exhibits

The exhibits filed or furnished as part of this Quarterly
Report on Form 10-Q are set forth below.

    Exhibit No.
     
    Description

    31.1*
     
    Certification of Principal Executive and Principal Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as amended
  
    32.1*
     
    Certification of Principal Executive and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
  
    101.INS*
     
    XBRL Instance Document
  
    101.SCH*
     
    XBRL Schema Document
  
    101.CAL*
     
    XBRL Calculation Linkbase Document
  
    101.DEF*
     
    XBRL Definition Linkbase Document
  
    101.LAB*
     
    XBRL Label Linkbase Document
  
    101.PRE*
     
    XBRL Presentation Linkbase Document

    *
    Filed herewith. 

 22 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

    Dated: August 19, 2025
    
    MOSAIC IMMUNOENGINEERING, INC.
     
    /s/ Steven King                                     
    
    Steven King. President, Chief Executive Officer, Director
    (Principal Executive Officer, Principal Financial Officer and
    Principal
    Accounting Officer)

 23